Biofarm records a net profit of RON 70.9 million in 2022

By Deniza Cristian

Biofarm, one of the biggest drug manufacturers in Romania, has reported positive developments for the preliminary (unaudited) results of 2022, recording a turnover of RON 277 million, up 16 percent compared to 2021, and a net profit of RON 70.9 million, up

18 percent. “One of our main objectives is to constantly increase turnover by developing and launching new products. In 2022, through sustained investment, we launched 18 new products in categories such as Pain Management, Immunity & Well-being or Bloating and strengthened our position on the local pharmaceutical market. With the new production facility in which we have invested more than EUR 44 million, we aim to grow and develop a competitive product portfolio based on the real needs of the market, both locally and internationally,” said CEO Catalin Vicol.

Biofarm is one of the leading players in the local pharmaceutical industry, ranking third in the Consumer Healthcare (CHC) category by volume in 2022.

Biofarm owns one of the most modern drug factories in Romania, spanning over 10,000 square metres and four production streams.

The new manufacturing facility is a key pillar in achieving the company’s strategic objectives: portfolio development through line extensions, new product launches, and expansion into foreign markets.

Evangelos Kalamakis has joined SOFMEDICA GROUP as the Managing Director of SOFMEDICA. Over the last 28 years, he has accumulated vast experience in project finance, investment banking, and real estate management, and a broad understanding of the Eastern European market. Kalamakis also has substantial experience in the corporate governance of regulated entities, an area where he has held various board positions.

Frank Loeffler is the new General Manager of Roche Romania. With more than 20 years of experience in the pharmaceutical industry, he started his career with Roche Germany in 2001 in the commercial department. Since 2011, he has held various management roles responsible for audit and compliance activities for Roche affiliates across EMEA and Asia. Since November 2018, Frank had been serving as the General Manager for East Africa. industry, serving public and private hospitals and health facilities,” says Iulia Nartea, general manager at Stericycle Romania. Sterilisation is one of the more sustainable methods of treating medical waste. The new facility uses pressurised steam and high temperatures to sterilise medical waste collected from healthcare institutions in the region. This helps remove the risk of infection, thereby protecting both local communities and the environment.

Mariya Popova is Bayer's new Head of Communications, Public Affairs, Science, and Sustainability in Romania, Bulgaria, and the Republic of Moldova. Mariya Popova has been a part of the Bayer family since 2018. She joined the Country Group as a Business Partner for the Consumer Health and Pharmaceuticals divisions.